Financial Counselors Inc. Buys 221 Shares of CVS Health Co. (NYSE:CVS)

Financial Counselors Inc. raised its stake in shares of CVS Health Co. (NYSE:CVS) by 0.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 90,846 shares of the pharmacy operator’s stock after purchasing an additional 221 shares during the period. Financial Counselors Inc.’s holdings in CVS Health were worth $5,712,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth $31,000. Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter valued at $32,000. First Community Trust NA lifted its position in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the 3rd quarter worth $33,000. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research report on Monday. Mizuho decreased their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft dropped their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Truist Financial restated a “buy” rating and set a $67.00 price target (down previously from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Finally, UBS Group lifted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $70.33.

CVS Health Stock Performance

CVS Health stock opened at $59.96 on Friday. CVS Health Co. has a fifty-two week low of $52.71 and a fifty-two week high of $83.25. The company has a market capitalization of $75.45 billion, a PE ratio of 15.22, a P/E/G ratio of 1.02 and a beta of 0.55. The company has a 50 day moving average price of $59.33 and a 200-day moving average price of $58.73. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business earned $2.21 EPS. As a group, equities analysts forecast that CVS Health Co. will post 5.37 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.